nejm.org· Henry T. HoffmanUniversity of Iowa, Iowa CityHarry QuonJohns Hopkins University, BaltimoreChristopher H. RassekhUniversity of Pennsylvania, PhiladelphiaHariz HassanRiboX Therapeutics, Cambridge, MA·· 1 day agoPickScore52
In Vivo Aquaporin-1 Circular RNA Therapy for Radiation-Induced Xerostomia
In Vivo Aquaporin-1 Circular RNA Therapy for Radiation-Induced Xerostomia
In brief
A study by RiboX Therapeutics with the University of Iowa, Johns Hopkins University and the University of Pennsylvania, published in NEJM Volume 395, Issue 16, pages 1659-1661, reports circular RNA encoding Aquaporin-1 administered in vivo to treat radiation-induced xerostomia; the feed provides only the abstract, with no full text.
Why it matters
In vivo delivery of Aquaporin-1 circular RNA offers a new nucleic acid drug approach to radiation-induced xerostomia.
Source: nejm.org · nejm.org